General Information of Drug (ID: DM0T3YH)

Drug Name
Indinavir Drug Info
Synonyms
Crixivan; IDV; Indinavir [USAN]; L 735524; Crixivan (TM); Crixivan (TN); L-735 524; L-735524; MK-639; Propolis+Indinavir; RS-253; L-735,524; Indinavir, Sulfate (1:1); Indinavir (*1:1 Sulfate salt*); N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE; Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide; (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide; (2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Approved [1]
Coronavirus Disease 2019 (COVID-19) 1D6Y Investigative [2]
Therapeutic Class
Anti-HIV Agents
Cross-matching ID
PubChem CID
5362440
ChEBI ID
CHEBI:44032
CAS Number
150378-17-9
TTD ID
D0V7CF
VARIDT ID
DR00299
INTEDE ID
DR0871
ACDINA ID
D00328

Full List of Drug Formulations Containing This Drug

Indinavir 400 mg capsule
Company Formulation ID FDA Description
Rebel Distributors; State of Florida DOH Central Pharmacy F10585 Anhydrous lactose; Sodium lauryl sulfate; Magnesium stearate; Titanium dioxide; Silicon dioxide; Gelatin
Merck Sharp & Dohme F10584 Anhydrous lactose; Magnesium stearate; Titanium dioxide; Gelatin, unspecified
Avera McKennan Hospital; Stat Rx USA F10586 Anhydrous lactose; Magnesium stearate; Titanium dioxide; Gelatin
------------------------------------------------------------------------------------
Indinavir Sulfate eq 400mg base capsule
Company Formulation ID FDA Description
Merck Sharp Dohme F23347 Anhydrous Lactose; Magnesium Stearate; Gelatin; Titanium Dioxide
------------------------------------------------------------------------------------
Indinavir 200 mg capsule
Company Formulation ID FDA Description
Merck Sharp & Dohme F10583 Anhydrous lactose; Magnesium stearate; Titanium dioxide; Gelatin, unspecified
------------------------------------------------------------------------------------

References

1 Approved antiretroviral drugs. Antiretroviral Drugs. Company report of AVERT. 2009.
2 Old Drugs for Newly Emerging Viral Disease, COVID-19: Bioinformatic Prospective